Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Nature Communications|October 28, 2021
A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signalingDaipayan Banerjee, Kurt Langberg, Salar Abbas, et al.BMC Cell Biology|March 20, 2013
Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoaLuis Korrodi-Gregório, Mónica Ferreira, Ana Paula Vintém, et al.Journal of Molecular and Cellular Cardiology|January 1, 2019
High-content phenotypic assay for proliferation of human iPSC-derived cardiomyocytes identifies L-type calcium channels as targetsLaura A Woo, Svyatoslav Tkachenko, Mei Ding, et al.Iscience|August 22, 2024
Multi-omic analysis reveals VEGFR2, PI3K, and JNK mediate the small molecule induction of human iPSC-derived cardiomyocyte proliferationLaura A Woo, Kaitlyn L Wintruba, Bethany Wissmann, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2018
Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancerLei Shi, Kang Li, Yizhan Guo, et al.Oncogene|September 22, 2019
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitorsCaitlin M O'Connor, Daniel Leonard, Danica Wiredja, et al.Cell|April 22, 2020
Selective PP2A Enhancement through Biased Heterotrimer StabilizationDaniel Leonard, Wei Huang, Sudeh Izadmehr, et al.Nature|September 16, 2014
Discovery and characterization of small molecules that target the GTPase RalChao Yan, Degang Liu, Liwei Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47)Craig L Slingluff, Gina R Petroni, Kerrington R Molhoek, et al.Cancer Research|January 24, 2018
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate CancerKimberly McClinch, Rita A Avelar, David Callejas, et al.Pageof 14